Samchundang Pharm Co Ltd (000250) · Earnings Release

Samchundang Pharm Co Ltd (000250) · Other

Extraordinary shareholders' meeting to appoint a former Financial Supervisory Service (FSS) official as a new outside director on June 30, 2026. Low importance is estimated as board changes typically have minimal immediate price impact, scheduled.

6/30/2026, 12:00:00 AM

LigaChem Biosciences Inc (141080) · Earnings Release

The company's quarterly earnings report is scheduled for May 18, 2026; a 5-10% price impact is estimated based on historical volatility, scheduled.

5/18/2026, 12:00:00 AM

Celltrion Inc (068270) · Earnings Release

Celltrion is scheduled to announce its Q1 2026 earnings on May 8, 2026. Analysts forecast consolidated sales of approximately 1.12 trillion KRW and an operating profit of around 314 billion KRW, which is estimated to have a medium market impact (≥5%) scheduled.

5/8/2026, 12:00:00 AM

Samsung Biologics Co Ltd (207940) · Other

The company's labor union has threatened its first-ever general strike to begin on May 1, 2026, following the breakdown of wage negotiations. Analysts forecast a price impact of over 10% due to significant operational risks, expected.

5/1/2026, 12:00:00 AM

Celltrion Inc (068270) · Other

Celltrion applied for marketing authorization to the European Medicines Agency (EMA) for 'Herzuma SC', a subcutaneous formulation of its breast cancer biosimilar Trastuzumab, on April 30, 2026. This first-in-class formulation is estimated to have a high market impact (≥10%) due to its significant competitive advantage.

4/30/2026, 12:00:00 AM

Yuhan Corp (000100) · Earnings Release

Yuhan Corp. announced Q1 2026 earnings. Consolidated revenue was KRW 526.8B (+7.2% YoY) and operating profit was KRW 8.8B (+37.3% YoY). Operating profit missed market expectations due to the delayed recognition of a milestone payment for Lazertinib. Due to the earnings miss, a ~5% price impact is expected.

4/30/2026, 12:00:00 AM